Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

October 28, 2014 by Alan Khadavi

Stepping Down Asthma Treatment

Stepping down asthma treatment is a way to manage patients over time.  There can be benefit or harm by stepping down asthma medication.  Many factors need to be considered which I will discuss ahead.

Asthma is a chronic inflammatory airway disease related to genetic and environmental factors.  A stepwise approach by the National Asthma Education and Prevention Program has been advocated.  Individuals who have poor control are at high risk for exacerbations and patients with good asthma control are at low risk for exacerbation and are candidates to “step down”.  The most recent guidelines suggest to step down when asthma has been controlled for 3 months, with a reduction of corticosteroid dose between 25-50%.

Reasons to step down asthma therapy are to decrease potential long term side effects of medications.  Although asthma medications are generally safe and well tolerated long term, there are potential side effects.  Also, patients may prefer to avoid medications.  Cost also can be a factor due to the Affordability Care Act, where many costs have been pushed to the consumer including medications.

Stepping down asthma medication may lead to an increased risk of an exacerbation.  The risk of stepping down from a combined inhaled corticosteroid-long term beta agonist (ICS-LABA) to an ICS is not well characterized and needs to be studied more.

Reducing the ICS dose can be accomplished by changing the frequency to once daily from twice daily or reducing the overall dose 25-50% percent.

Changing from an ICS to Singulair, can lead to a treatment failure (30%), a recent study showed.

Any method of stepping down therapy may be safe options for patients with stable asthma, however there is additional risk of exacerbations than just continuing the current asthma medication type and dose.

Stepping down therapy may not be needed if patients were started on a lower step of asthma care.  Studies have shown there is only a very small benefit of starting high-dose ICS when treating asthma.

Before stepping up, assess for factors that may be interfering with treatment response, (adherence, technique, allergy triggers).  Before stepping down, the risks and benefits need to be discussed with the patients.  Lung function or pulmonary function testing should be assessed.

 

Filed Under: Allergy Medicine, Asthma, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page